Vertex Announces Progress In Povetacicept Development Program And Presentation Of New Data At American Society Of Nephrology Kidney Week

Vertex Pharmaceuticals Inc VRTX:

• VERTEX ANNOUNCES PROGRESS IN POVETACICEPT DEVELOPMENT PROGRAM AND PRESENTATION OF NEW DATA AT AMERICAN SOCIETY OF NEPHROLOGY KIDNEY WEEK

• VERTEX PHARMACEUTICALS INC - FDA GRANTS ROLLING REVIEW FOR POVETACICEPT IN IGA NEPHROPATHY

• VERTEX PHARMACEUTICALS INC: EXPECTS TO SUBMIT FIRST MODULE TO FDA FOR POTENTIAL ACCELERATED APPROVAL BEFORE END OF 2025

• VERTEX PHARMACEUTICALS INC: REMAINS ON TRACK TO COMPLETE FULL BLA SUBMISSION FOR ACCELERATED APPROVAL IN U.S. IN FIRST HALF OF 2026